Breast Cancer with Low Recurrence Score on Oncotype DX(©): Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation

INTRODUCTION: The 21-gene recurrence score assay Oncotype DX(©) (ODX) has clear prognostic and predictive value regarding adjuvant chemotherapy. However, recent studies have shown the clinical distinctiveness of both BRCA1/2–driven early breast cancer (EBC) and invasive lobular (ILC) breast cancers....

Descripción completa

Detalles Bibliográficos
Autores principales: Zarbiv, Yonaton, Wygoda, Yael Berner, Grinshpun, Albert, Hamburger, Tamar, Sella, Tamar, Breuer, Shani, Maimon, Ofra, Rottenberg, Yakir, Peretz, Tamar, Kadouri, Luna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681955/
https://www.ncbi.nlm.nih.gov/pubmed/35751801
http://dx.doi.org/10.1007/s40487-022-00202-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681955/
https://www.ncbi.nlm.nih.gov/pubmed/35751801
http://dx.doi.org/10.1007/s40487-022-00202-7

Ejemplares similares